Siemens Shares Face Investor Caution Despite Robust Performance

Siemens posts record orders and raises guidance, but its stock falls as investor focus shifts to the planned separation of its medical tech unit, Siemens Healthineers.

A record order backlog, an upgraded earnings forecast, and an ongoing multi-billion euro share buyback program have not been enough to buoy Siemens' stock price. The market's focus has shifted decisively to the planned strategic separation of its medical technology subsidiary, Siemens Healthineers, creating a paradox where strong operational results are being overshadowed by corporate restructuring uncertainty.

Financial Performance Exceeds Expectations

Siemens delivered a powerful start to its 2026 fiscal year. On a comparable basis, new orders surged by 10% to reach €21.4 billion, while revenue increased by 8% to €19.1 billion. Growth was broad-based across all industrial divisions. Industrial profit came in at €2.9 billion, yielding a margin of 15.6%, and adjusted earnings per share advanced to €2.80.

The data center business stood out as a particular highlight, posting a remarkable 35% revenue increase, largely fueled by robust cloud demand in the United States. The company's order backlog swelled to a new record of €120 billion. A book-to-bill ratio of 1.12 indicates that new business is being secured faster than it can be converted into sales.

In response to these figures, management raised its full-year guidance for adjusted earnings per share. The new range is €10.70 to €11.10, up from the previous forecast of €10.40 to €11.00. Chief Financial Officer Ralf Thomas also indicated that revenue growth is now expected to land in the upper half of the projected six to eight percent range.

Strategic Shift Creates Near-Term Headwinds

The primary source of investor apprehension is the proposed strategic realignment involving Siemens Healthineers. The plan involves distributing approximately 30% of Healthineers shares directly to Siemens shareholders, a move that would relinquish Siemens' controlling majority in the medical technology unit. In the medium term, Healthineers would be accounted for as a significant minority stake.

While this corporate simplification aims to sharpen Siemens' long-term focus on its industrial and infrastructure core, it has introduced significant near-term questions. Management has stated that specific structural details and a definitive timeline will not be clarified until early in the second quarter. The process also requires approval from both companies' shareholder meetings and must navigate regulatory clearances. This cloud of uncertainty is applying persistent pressure on the equity.

The shares closed recently at €229.85, trading roughly 12% below their 52-week high of €261.55. The stock has also breached its 200-day moving average—a development chart analysts view as a technically significant signal.

Growth Initiatives and Capital Allocation

Alongside the Healthineers transaction, Siemens is advancing several other strategic fronts. A collaboration with NVIDIA is focused on developing AI-driven industrial automation solutions, with the Siemens Electronics Factory in Erlangen slated to become the first reference project starting in 2026. Separately, the company is investing approximately €200 million to transform its Amberg facility into a fully AI-controlled factory by 2030.

The acquisition of simulation software specialist Altair Engineering, valued at around $10 billion, has been finalized. Market experts increasingly view the integration of Altair as a potential long-term catalyst for Siemens' high-margin Digital Industries segment. Meanwhile, the share repurchase program is progressing significantly faster than initially planned, with approximately €4.4 billion already deployed. An additional 18 million treasury shares are scheduled to be retired in March.

Two upcoming events will be critical in determining whether operational strengths can regain market attention. Early in Q2, management is set to provide the concrete terms of the Healthineers transaction. This will be followed by the release of second-quarter results on May 13, 2026, offering the first evidence of whether the strong order momentum, particularly in data centers, has been sustained.